Author

K.-M. Hardisty

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:variant calling· 2 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

G. Williams· 2 shared M. Loddo· 2 shared R. Thatcher· 2 shared T. Haddow· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. Williams

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 27, 2021

Utilisation of semiconductor sequencing for detection of actionable fusions in solid tumors

M. Loddo, K.-M. Hardisty, T. Haddow…·G. Williams

This study demonstrates that semiconductor sequencing can effectively detect actionable fusions in formalin-fixed solid tumor samples, identifying 7.4% of cases with potential targeted therapies.

DOI 10.1101/2021.01.27.428383

humanbulk RNA-seq

𝕏 PostBluesky

PathologybioRxivJan 11, 2021

Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma

G. Williams, R. Thatcher, K.-M. Hardisty, M. Loddo

This study uses semiconductor sequencing to identify actionable mutations in glioblastoma patients, revealing potential therapeutic targets and linking them to targeted therapies and immunotherapies.

DOI 10.1371/journal.pone.0245817

humanbulk RNA-seq

𝕏 PostBluesky